TENAX THERAPEUTICS, INC. Amortization of Debt Issuance Costs
TENAX THERAPEUTICS, INC. (TENX) reported Amortization of Debt Issuance Costs of $128.62 thousand for the 12-month period ending 2013-04-30, per its 10-K filed 2013-06-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2013-06-26
- TENAX THERAPEUTICS, INC. amortization of debt issuance costs for the quarter ending 2013-04-30 was $32.15K, a 200.00% increase year-over-year.
- TENAX THERAPEUTICS, INC. amortization of debt issuance costs for the quarter ending 2013-01-31 was $32.15K, a 0.00% change year-over-year.
- TENAX THERAPEUTICS, INC. amortization of debt issuance costs for the quarter ending 2012-10-31 was $32.15K, a 0.00% change year-over-year.
- TENAX THERAPEUTICS, INC. amortization of debt issuance costs for the quarter ending 2012-07-31 was $32.15K, a 200.00% increase year-over-year.
- TENAX THERAPEUTICS, INC. amortization of debt issuance costs for fiscal 2013 was $128.62K, a 20.00% increase from fiscal 2012.
- TENAX THERAPEUTICS, INC. amortization of debt issuance costs for fiscal 2012 was $107.18K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2013-04-30 | $32.15K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26 | $64.31K derived: sum of 2 quarters · filed 2013-06-26 | $96.46K derived: sum of 3 quarters · filed 2013-06-26 | $128.62K 10-K · filed 2013-06-26 |
| 2013-01-31 | $32.15K 10-Q · filed 2013-03-18 | $64.31K derived: sum of 2 quarters · filed 2013-03-18 | $96.46K 10-Q · filed 2013-03-18 | $107.18K derived: sum of 4 quarters · filed 2013-06-26 |
| 2012-10-31 | $32.15K 10-Q · filed 2012-12-14 | $64.31K 10-Q · filed 2012-12-14 | $75.03K derived: sum of 3 quarters · filed 2013-06-26 | $107.18K derived: sum of 4 quarters · filed 2013-06-26 |
| 2012-07-31 | $32.15K 10-Q · filed 2012-09-19 | $42.87K derived: sum of 2 quarters · filed 2013-06-26 | $75.03K derived: sum of 3 quarters · filed 2013-06-26 | $107.18K derived: sum of 4 quarters · filed 2013-06-26 |
| 2012-04-30 | $10.72K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26 | $42.87K derived: sum of 2 quarters · filed 2013-06-26 | $75.03K derived: sum of 3 quarters · filed 2013-06-26 | $107.18K 10-K · filed 2013-06-26 |
| 2012-01-31 | $32.15K 10-Q · filed 2013-03-18 | $64.31K derived: sum of 2 quarters · filed 2013-03-18 | $96.46K 10-Q · filed 2013-03-18 | |
| 2011-10-31 | $32.15K 10-Q · filed 2012-12-14 | $64.31K 10-Q · filed 2012-12-14 | ||
| 2011-07-31 | $10.72K 10-Q · filed 2012-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |